Brazilian hepatitis B vaccine: A six-year follow-up in adolescents

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 8, 2012, Pages 1060-1063

  Alexandre, Kamilla Vêncio Frauzino ^a   Martins, Regina Maria Bringel ^a   de Souza, Márcia Maria ^a   Rodrigues, Isolina Maria Xavier ^a   Teles, Sheila Araujo ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Adolescents; Follow up; Hepatitis B vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BRAZIL; CHILD; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOLOGY;

ADOLESCENT; BRAZIL; CHILD; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; YOUNG ADULT;

EID: 84871808042     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000800016     Document Type: Article

References (20)

1. Alfaleh F, Alshehr S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA 2008. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 57: 404-409.
2. Beasley RP 2009. Development of hepatitis B vaccine. JAMA 302: 322-324.
3. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF 2008. Twentytwo years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine 26: 6587-6591.
4. Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, Kamili S, Drobeniuc J, Hu DJ 2012. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine 30: 1644-1649.
5. Chaves SS, Groeger J, Helgenberger L, Auerbach SB, Bialek SR, Hu DJ, Drobeniuc J 2010. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine 28: 2860-2864.
6. Gilca V, de Serres G, Boulianne N, de Wals P, Murphy D, Trudeau G, Masse R, Duval B 2009. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later. Vaccine 27: 6048-6053.
7. Hieu NT, Kim KH, Janowicz Z, Timmermans I 2002. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 20: 1803-1808.
8. Ioshimoto LM, Rissato ML, Bonilha VS, Miyaki C, Raw II, Granovski N 1999. Safety and immunogenicity of hepatitis B vaccine Butang in adults. Rev Inst Med Trop Sao Paulo 41: 191-193.
9. Jilg W, Schmidt M, Deihrardt F 1988. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 6: 201-207.
10. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS 2005. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142: 333-341.
11. Moraes JC, Luna EJ, Grimaldi RA 2010. Immunogenicity of the Brazilian hepatitis B vaccine in adults. Rev Saude Publica 44: 353-359.
12. Nakao K, Hamasaki K, Wakihama N, Maeda M, Ohtsubo N, Sagiike T, Ichikawa T, Ishikawa H, Eguchi K, Ishii N 2003. Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus. Vaccine 21: 3789-3794.
13. O'Halloran JA, de Gascun CF, Dunford L, Carr MJ, Connell J, Howard R, Hall WW, Lambert JS 2011. Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection. J Clin Virol 52: 151-154.
14. ® vaccine in adolescents from low income families in Central Brazil. Mem Inst Oswaldo Cruz 101: 251-256.
15. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. 2010. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 28: 623-31.
16. Romano L, Paladini S, Van Damme P, Zanetti AR 2011. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 43 (Suppl. 1): S2-S7.
17. Shouval D 2003. Hepatitis B vaccines. J Hepatol 39 (Suppl.): S70-S76.
18. Vijayakumar V, Hari R, Parthiban R, Mehta J, Thyagarajan SP 2004. Evaluation of immunogenicity and safety of Genevac B: a new recombinant hepatitis B vaccine in comparison with Engerix B and Shanvac B in healthy adults. Indian J Med Microbiol 22: 34-38.
19. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A 2002. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 325: 569.
20. Zhang Y, Ma JC, Qi SX, Wang F, Zhao C, Bi SL 2011. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities. Vaccine 29: 3905-3908.